Minimal toxicity after proton beam therapy for prostate and pelvic nodal irradiation: results from the proton collaborative group REG001-09 trial.

about

Minimal toxicity after proton beam therapy for prostate and pelvic nodal irradiation: results from the proton collaborative group REG001-09 trial.

Item

http://www.wikidata.org/entity/Q50072796

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Minimal toxicity after proton ...... orative group REG001-09 trial.

@en

Minimal toxicity after proton ...... orative group REG001-09 trial.

@nl

type

Item

label

Minimal toxicity after proton ...... orative group REG001-09 trial.

@en

Minimal toxicity after proton ...... orative group REG001-09 trial.

@nl

prefLabel

Minimal toxicity after proton ...... orative group REG001-09 trial.

@en

Minimal toxicity after proton ...... orative group REG001-09 trial.

@nl

P1476

Minimal toxicity after proton ...... orative group REG001-09 trial.

@en

P2093

Adeel Kaiser

http://www.w3.org/2001/XMLSchema#string

Carl J Rossi

http://www.w3.org/2001/XMLSchema#string

Carlos Vargas

http://www.w3.org/2001/XMLSchema#string

Gary Larson

http://www.w3.org/2001/XMLSchema#string

George E Laramore

http://www.w3.org/2001/XMLSchema#string

Henry Tsai

http://www.w3.org/2001/XMLSchema#string

J Ben Wilkinson

http://www.w3.org/2001/XMLSchema#string

Michael D Chuong

http://www.w3.org/2001/XMLSchema#string

William Hartsell

http://www.w3.org/2001/XMLSchema#string

P2860

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients.

Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer.

RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer

Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02.

An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions

Radiation dose-volume effects in the stomach and small bowel.

Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer.

Whole-pelvic radiotherapy with spot-scanning proton beams for uterine cervical cancer: a planning study

Comparison of dosimetric parameters and acute toxicity after whole-pelvic vs prostate-only volumetric-modulated arc therapy with daily image guidance for prostate cancer.

Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer.

P304

368-374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/0284186X.2017.1388539

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29034790

http://www.w3.org/2001/XMLSchema#string

P921

collaboration